Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Imbrium Therapeutics logo — company profile

Imbrium Therapeutics

Founded 2018 United States Stamford, United States 30 employees Biotechnology, Health and Wellness +1

General Information

Company Name Imbrium Therapeutics
Founded Year 2018
Location United States Stamford, United States +1
Employees 30
Industries Biotechnology, Health and Wellness, Pharmaceutical
Social

Get notified when Imbrium Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Imbrium Therapeutics

Imbrium Therapeutics is a clinical-stage biopharmaceutical company founded in 2018, dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. The company's focus spans oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to pain management. Operating as a subsidiary of Purdue Pharma L.P., Imbrium prioritizes addressing unmet needs of patients, physicians, and health systems globally. The company has established a robust and diversified pipeline of investigational drug candidates. Additionally, Imbrium actively engages in collaborations with industry and academic partners to identify and advance impactful medicines. It is essential to note that discussions on Imbrium's LinkedIn posts may include investigational products that are not yet approved by the FDA, and therefore, their safety and effectiveness have not been established. Consequently, there is no guarantee that these products will successfully complete development or gain FDA approval. Imbrium operates within the realms of Biotechnology, Health and Wellness, and Pharmaceutical industries, demonstrating a commitment to offering innovative solutions in these sectors.

No funding data available for Imbrium Therapeutics yet.

Get notified when Imbrium Therapeutics raises funding

Imbrium Therapeutics Alternatives & Competitors

Imbrium Therapeutics vs
MedVasc
MedVasc Sweden

The new painless treatment for Varicose Veins

Seed
4 employees
Medical Devices
Imbrium Therapeutics vs
Mapp Biopharmaceutical Inc
Mapp Biopharmaceutical Inc United States

Developing monoclonal antibody drugs for unmet needs in public health and biodefense.

Grant
66 employees
Biotechnology, Health and Wellness
Imbrium Therapeutics vs
Bridge Therapeutics Inc.
Bridge Therapeutics Inc. United States

Safe alternatives to Opioids

6 employees

FAQ About Imbrium Therapeutics

Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches...
Imbrium Therapeutics was founded in 2018.
Imbrium Therapeutics is headquartered in Stamford, United States.
Imbrium Therapeutics operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
Imbrium Therapeutics has approximately 30 employees.
Top alternatives and competitors to Imbrium Therapeutics include MedVasc, Mapp Biopharmaceutical Inc, Bridge Therapeutics Inc., HbO2 Therapeutics, Cadence Neuroscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Imbrium Therapeutics and MedVasc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Imbrium Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes